🎉 ECLLA Club Programme 2026 Launch! Join Our First Educational Session “CLL Essentials, Diagnostics & Treatment Pathways” | July, 29th – REGISTRATION OPEN

Jul 4, 2026 | ECLLA Club, News

Dear ECLLA Members, We are delighted to announce the official launch of the ECLLA Club Programme 2026 and to invite you to our first session, CLL Essentials, Diagnostics & Treatment Pathways. This interactive session combines an expert-led presentation with...

🎥 Recordings Now Available: ECLLA Multi-Stakeholder Discussion on Time Off Treatment in CLL

Jul 3, 2026 | EHA Panel 2026, News

The European CLL Association (ECLLA) is pleased to announce that recording of the multi-stakeholder panel discussion, “Time Off Treatment in CLL – Clinical Control and Patient Priorities in Fixed-Duration Treatment,” is now available to watch online. Held...

ECLLA Co-Founder Jan Rynne Joins European Discussion on the EU Biotech Act

Jul 3, 2026 | News

ECLLA is proud to share that our Co-Founder, Jan Rynne, recently joined the Cancer Patients Europe (CPE) Policy Webinar as a panellist to discuss the EU Biotech Act and its potential to improve clinical trials and access to innovative cancer treatments across Europe....

ECLLA Club in Development – First Session Coming Soon

Jul 3, 2026 | ECLLA Club, News

ECLLA Membership Club in Development – First Session Coming Soon ECLLA is pleased to share that preparations are underway for the first session of the ECLLA  Club, a new initiative being developed exclusively for ECLLA member organisations. The Membership Club will...

🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Prof Oliver Karanfilski

Jul 2, 2026 | ECLLA Policy Roundtabe, News

European CLL Association – ECLLA is proud to work alongside Prof Oliver Karanfilski, Professor of Hematology and Internal Medicine and Consultant Hematologist from Macedonia, whose expertise brings an essential perspective to our Medical Advisory Board. At the...